Association of multiplex-immunofluorescence (m-IF) and gene expression signature with prognosis and bevacizumab (bev) treatment outcomes in NRG oncology/NSABP C-08: Implications for combining immune checkpoint blockade (ICB) and bev

Katherine L. Pogue-Geile; Marion E Joy; Ying Wang; Rim S Kim; Patrick G Gavin; Debora Fumagalli; Greg Yothers; Carmen Joseph Allegra; Ashok Srinivasan; Melanie Finnigan; Samuel A. Jacobs; Thomas J. George; Jennifer Marie Suga; Judith O. Hopkins; Naoyuki G. Saito; Norman Wolmark; Soonmyung Paik; Peter C. Lucas

doi:10.1200/JCO.2022.40.4_suppl.140

YUHSpace

BROWSE

0 333

Cited 0 times in

Association of multiplex-immunofluorescence (m-IF) and gene expression signature with prognosis and bevacizumab (bev) treatment outcomes in NRG oncology/NSABP C-08: Implications for combining immune checkpoint blockade (ICB) and bev

Authors: Katherine L. Pogue-Geile ; Marion E Joy ; Ying Wang ; Rim S Kim ; Patrick G Gavin ; Debora Fumagalli ; Greg Yothers ; Carmen Joseph Allegra ; Ashok Srinivasan ; Melanie Finnigan ; Samuel A. Jacobs ; Thomas J. George ; Jennifer Marie Suga ; Judith O. Hopkins ; Naoyuki G. Saito ; Norman Wolmark ; Soonmyung Paik ; Peter C. Lucas